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Research
Non-Hodgkin lymphomas (NHLs) are a het-
erogeneous group of B- and T-cell neoplasms 
arising primarily in the lymph nodes. Incidence 
rates have nearly doubled in Western countries 
since the 1970s, although no further rise has 
been observed since the mid-1990s (Dreiher 
and Kordysh 2006). Established risk factors 
include genetic susceptibility and previous his-
tory of malignant disease (Wang et al. 2007). 
Immunological conditions are also related to 
this group of cancers, as evidenced by a more 
than 100-fold increased risk of NHL among 
organ transplant recipients receiving immuno-
suppressive therapy (Fisher and Fisher 2004) 
and an increased incidence among subjects with 
primary immunodeficiency and autoimmune 
diseases (Vineis et al. 2000). However, these 
factors, in combination with longer life spans 
and changes in diagnostic patterns, cannot 
explain all cases, and many researchers specu-
late that the increase is partly due to exposure 
to environmental agents, including organo-
chlorines (Hardell and Axelson 1998).
Dichlorodiphenyltrichlorethane (DDT) 
and other organo  chlorines are carcinogenic 
in animals (International Agency for Research 
on Cancer 1987), and the production and 
environmental release of these compounds 
with subsequent bioaccumulation accelerated 
during the decades after 1945 (World 
Resources Institute 1990), coinciding with 
increasing incidence rates for NHL in Western 
populations. Organo  chlorines are ubiquitously 
present as a mixture of mother compounds 
and metabolites in the environment and are 
characterized by high lipid solubility, environ-
mental persistence, bioaccumulation (Agency 
for Toxic Substances and Disease Registry 
1993), and long biological half-lives in human 
tissue (Wolff et al. 2000). Several studies have 
described immunotoxicity of selected organo-
chlorines (Heilmann et al. 2006; Reed et al. 
2004; Tryphonas et al. 2003).
The evidence relating organo  chlorines to 
NHL risk has been reviewed (Dreiher and 
Kordysh 2006) and the association remains 
unclear, with some studies reporting associa-
tions and others finding none. Reasons for 
these discrepancies may include low statis-
tical power or imprecise exposure measure-
ments, such as surrogate measures including 
occupation or self-reported questionnaires 
gathered after diagnosis. More recent studies 
have evaluated biological exposure measure-
ments and have more consistently reported 
associations between NHL risk and various 
organo  chlorine pesticides and polychlorinated 
biphenyl (PCB) congeners (Bertrand et al. 
2010; Cantor et al. 2003; De Roos et al. 2005; 
Engel et al. 2007; Laden et al. 2010; Quintana 
et al. 2004; Spinelli et al. 2007). However, the 
specific compounds identified were not con-
sistent among the studies, and different bio-
logical media were used. Questions pertaining 
to the best quantification of biological expo-
sure have been raised (Aronson et al. 2000; 
Whitcomb et al. 2005), and adipose tissue 
samples have been regarded by various authors 
(Allam and Lucena 2001; Hardell et al. 1996; 
Quintana et al. 2004) as the preferred indica-
tor of human exposure because organo  chlorine 
levels are known to be higher in adipose tissue 
and more representative of the cumulative 
internal exposure. However, only two studies 
have previously measured organo  chlorines in 
adipose tissue (Hardell et al. 1996; Quintana 
et al. 2004), and in both studies the adipose 
tissue was sampled after the diagnosis, render-
ing results difficult to interpret because treat-
ment may affect subsequent organo  chlorine 
concentrations (Gammon et al. 1996; Morgan 
and Roan 1971).
In the present study, we investigated the 
hypothesis that organo  chlorines are related to 
an increased NHL risk, and we are the first to 
use adipose tissue sampled before the NHL 
diagnosis to assess organo  chlorine exposures 
in a population-based setting.
Materials and Methods
Between December 1993 and May 1997, 
160,725 persons 50–64 years of age were 
invited to participate in the prospective Diet, 
Cancer and Health study. The participants had 
to be born in Denmark, live in Copenhagen 
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Ba c k g r o u n d: Exposure to organo  chlorines has been examined as a potential risk factor for 
non-Hodgkin lymphoma (NHL), with inconsistent results that may be related to limited statistical 
power or to imprecise exposure measurements. 
oB j e c t i v e: Our purpose was to examine associations between organo  chlorine concentrations in 
prediagnostic adipose tissue samples and the risk of NHL.
Me t h o d s : We conducted a case–cohort study using a prospective Danish cohort of 57,053 persons 
enrolled between 1993 and 1997. Within the cohort we identified 256 persons diagnosed with 
NHL in the population-based nationwide Danish Cancer Registry and randomly selected 256 sub-
cohort persons. We measured concentrations of 8 pesticides and 10 polychlorinated biphenyl (PCB) 
congeners in adipose tissue collected upon enrollment. Associations between the 18 organo  chlorines 
and NHL were analyzed in Cox regression models, adjusting for body mass index.
re s u l t s: Incidence rate ratios and confidence intervals (CIs) for interquartile range increases in 
concentrations of dichlorodiphenyltrichlorethane (DDT), cis-nonachlor, and oxychlordane were 
1.35 (95% CI: 1.10, 1.66), 1.13 (95% CI: 0.94, 1.36), and 1.11 (95% CI: 0.89, 1.38), respectively, 
with monotonic dose–response trends for DDT and cis-nonachlor based on categorical models. The 
relative risk estimates were higher for men than for women. In contrast, no clear association was 
found between NHL and PCBs.
co n c l u s i o n: We found a higher risk of NHL in association with higher adipose tissue levels of 
DDT, cis-nonachlor, and oxychlordane, but no association with PCBs. This is the first study of 
organo  chlorines and NHL using prediagnostic adipose tissue samples in the exposure assessment and 
provides new environmental health evidence that these organo  chlorines contribute to NHL risk.
key w o r d s : adipose tissue, case–cohort, non-Hodgkin lymphoma, organo  chlorines. Environ Health 
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or Aarhus, and be cancer free at the time of 
invitation. A total of 57,053 persons of those 
invited were enrolled in the cohort. Upon 
enrollment, each participant completed self-
administered questionnaires on dietary hab-
its, health status, family history of cancer, 
social factors, reproductive factors, and life-
style habits. Participation was based on written 
informed consent. Staff members in the study 
clinics obtained height and weight measure-
ments and took a buttock adipose tissue biopsy 
from each participant, yielding an average of 
29 mg (range, 1–97 mg) tissue. All samples 
were frozen at −20°C within 2 hr and put in 
liquid nitrogen vapor (maximum temperature, 
−150°C) for long-term storage within 8 hr of 
collection. The study was approved by regional 
ethics committees for Copenhagen and Aarhus.
Using the unique personal identification 
number allocated to every Danish citizen, 
we linked all cohort members to the Danish 
Central Population Registry to obtain infor-
mation on vital status, disappearance, and 
emigration. Follow-up for NHL started on 
the date of enrollment at one of the study 
clinics (baseline) and continued until date of 
diagnosis of any cancer (except nonmelanoma 
skin cancer), date of death, date of emigra-
tion, or 31 July 2008 (end of follow-up), 
whichever came first. The mean and maxi-
mum follow-up times were 9.6 and 15 years, 
respectively. Cancers diagnosed during 
follow-up were identified by linkage to the 
nationwide Danish Cancer Registry using the 
personal identification number.
We excluded 9 of the identified NHL 
cases because of the diagnosis of another previ-
ous cancer, resulting in 278 cases (152 men, 
126 women) with NHL. Stored adipose tissue 
was missing for 22 cases, which were therefore 
excluded. We used a case–cohort design within 
the Diet, Cancer and Health cohort. A sub-
cohort consisting of 256 persons was randomly 
selected among the entire cohort, regardless 
of case status. Of the final 512 participants, 
we excluded 17 cases and 11 subcohort per-
sons because of either insufficient availability 
of adipose tissue for organo  chlorine analysis 
or laboratory analysis errors, leaving 239 cases 
(126 men, 113 women) and 245 subcohort 
persons (126 men, 119 women).
Organo  chlorine analyses. The organo-
chlorines measured were 10 PCB con-
geners (congeners 99, 118, 138, 153, 156, 
170, 180, 183, 187, and 201) and 8 pesti-
cides analytes [p,p´-DDT, p,p´-dichloro-
diphenyldichloroethylene (p,p´-DDE), 
β-hexachlorocyclohexane, dieldrin, hexachloro-
benzene, cis-nonachlor, trans-nonachlor, and 
oxychlordane].
Samples were analyzed at the Centre de 
toxicologie du Québec, Institut National de 
Santé Publique du Québec Quebec City, 
Quebec, Canada. Laboratory personnel 
were blind to the case status. The labora-
tory is accredited under ISO 17025 by the 
Canadian Standards Council and participates 
in many quality control programs, including 
the Northern Contaminants Program of the 
Ministry of the Environment of Ontario, the 
U.K. National External Quality Assessment 
Scheme, and the German External Quality 
Assessment Scheme.
The sample was aspirated from the needle 
into a vacuum-based collection vial. The tis-
sue samples were then fortified with internal 
standards, mixed with dichloromethane, and 
chemically dried using sodium sulfate. Part 
of the organic solvent was used to determine 
the percentage of total lipids in the sample. 
The remaining fraction was concentrated 
by evaporation, and purified using gel per-
meation chromatography, and cleaned up 
on a Florisil column (Agilent Technologies, 
Mississauga, Ontario, Canada). The extracts 
were analyzed on a gas chromatography/mass 
spectroscopy instrument (model 6890/5973; 
Agilent Technologies) using a DB-XLB cap-
illary column [60 m long, 0.25 mm inner 
diameter and 0.25 μm film thickness (Agilent 
Technologies)]. The measurement of ions 
generated after negative chemical ionization 
was performed in selective ion mode. The 
concentration calculations took the recov-
ery of isotopically labeled internal standards 
into account. For additional information on 
instrumentation and analytical protocols, 
see Supplemental Material, page S2 (http://
dx.doi.org/10.1289/ehp.1103573).
We determined the total lipid content 
of the designated extract using a gravimet-
ric method. A 200 μL sample was precisely 
weighed on an analytic balance, and the sol-
vent was evaporated at room temperature. The 
resulting lipid weight was adjusted to the ini-
tial sample weight, and the percentage of lipid 
content was calculated. The organo  chlorine 
concentrations were expressed in microgram 
per kilogram of lipids.
For each of the analytes, the limit of detec-
tion (LOD) was determined by first estimating 
the concentration equivalent to a signal:noise 
ratio of 3. We then measured 10 replicates of a 
sample with the analyte at concentrations 4–10 
times the estimated LOD and defined the final 
LOD as three times the standard deviation of 
the 10 replicates. The organo  chlorines could be 
divided into four groups according to LOD. 
Group 1 was PCB-99; group 2, p,p´-DDE, 
p,p´-DDT, and β-hexachlorocyclohexane; 
group 3, hexachloro  benzene; and group 4, all 
other compounds. The LOD was 1.00, 0.30, 
0.20, and 0.10 μg/kg for groups 1, 2, 3, and 
4, respectively. For each study sample, the 
LOD was adjusted according to the weight 
and lipid content of the sample, resulting in a 
wide range of sample-specific LODs for each 
compound.
Routine checks of the accuracy and pre-
cision of the organo  chlorine measurements 
were done using reference materials from 
the National Institute of Standards and 
Technology (Gaithersburg, MD, USA) and by 
participating in quality assessment schemes. 
The interday precision was 5.1–7.3% for the 
PCB congeners and 5.0–10.5% for the pes-
ticides. Based on spiked levels (5 μg/kg in 
corn oil, n = 3), recovery was 87–96% for the 
different PCB congeners and 70–94% for the 
organo  chlorine pesticides. For details con-
cerning analytical quality assurance/control 
and individual recoveries, see Supplemental 
Material, page S2 and Table S1 (http://dx.doi.
org/10.1289/ehp.1103573).
Statistical methods. In accordance with 
the sampling design, the incidence rate ratios 
(IRRs) for NHL were estimated by a Cox pro-
portional hazard model (PHREG in SAS, ver-
sion 9.1; SAS Institute Inc., Cary, NC, USA).
The two-sided 95% confidence interval 
(CI) and p-values were based on the robust 
estimates of the variance-covariance matrix 
(Barlow 1994) and the Wald’s test statistic for 
regression parameters in Cox regression mod-
els. All statistical tests were two sided, and 
statistical significance was defined as p < 0.05. 
Age was the time scale, ensuring the risk esti-
mate was based on comparisons of individ-
uals at the same age, thus adjusting for age 
(Thiebaut and Benichou 2004), and analyses 
were stratified according to sex.
Based on the exposure distribution among 
all participants with levels above the LOD, 
we generated five exposure groups (0th–
25th, 25th–50th, 50th–75th, 75th–90th, 
and > 90th percentiles) for each compound. 
Cutoff percentiles were based on exposure 
distribution among all participants because we 
hypothesized that exposure increased the risk 
for NHL. Thus, basing cutoff percentiles on 
the exposure of the subcohort alone may have 
resulted in relatively few cases in the lowest 
exposure category (reference group), possibly 
compromising statistical power when estimat-
ing IRRs for the upper exposure groups.
Relative risk was estimated by contrasting 
each of the upper exposure groups with the 
lowest exposure group. Case and subcohort 
members with organo  chlorine levels below the 
LOD were excluded instead of being assigned 
a value based on the LOD, as the LOD varied 
substantially among study samples because of 
differences in lipid content. We investigated 
the sensitivity of the results relating to this 
exclusion by repeating categorical analyses with 
persons who had organo  chlorine levels below 
their sample-specific LOD assigned as follows: 
If the LOD for their adipose sample was below 
the 25th percentile of the distribution of meas-
ured concentrations (based on all samples with 
values > LOD), the subject was assigned to the 
lowest exposure category. If the LOD for their Non-Hodgkin lymphoma and organochlorine exposure
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sample was above the 25th percentile of meas-
ured concentrations, they were assigned to a 
separate exposure group (modeled as a dummy 
variable). For linear analyses (of continuous 
exposures), the concentration for subjects with 
sample LODs below the 25th percentile was 
imputed as the specific LOD for the sample, 
whereas those with sample LODs above the 
25th percentile were included in a separate 
exposure group, as above. This strategy assumes 
no (categorical analyses) or low (linear analyses) 
exposure misclassification.
Analyses were conducted for individual 
organo  chlorines, as well as for the sum of PCB 
congeners, chlordanes (cis- and trans-nona-
chlor and the metabolite oxychlordane), and 
DDTs (DDT and DDE). In one of the analy-
ses, we grouped PCBs according to immuno-
toxicological properties (PCB congeners 138, 
153, and 180), as previously suggested (Van 
Den Heuvel et al. 2002). We evaluated the 
associations between each organo  chlorine and 
NHL risk using linear splines: first with three 
boundaries (25th, 50th, and 75th percentiles) 
and then with nine boundaries placed at the 
10th, 20th, 30th . . . 90th percentiles among 
all participants. The linearity was evaluated 
graphically in addition to being evaluated with 
a numerical test using the likelihood ratio test 
statistic to compare the model assuming lin-
earity with the linear spline model. Because 
none of the organo  chlorines deviated from lin-
earity (data not shown), we calculated IRR per 
interquartile range (IQR) based on the contin-
uous organo  chlorine concentrations. The IRRs 
for NHL in association with concentrations of 
individual organo  chlorines in adipose tissue 
were calculated with and without adjusting 
for body mass index (BMI) as a continuous 
variable. Obesity has previously been associ-
ated with NHL (Skibola 2007), and a high 
BMI could influence the adipose tissue con-
centration of the organo  chlorine compounds. 
We estimated the linear effect of exposure for 
participants below and above the median BMI 
(26.0 kg/m2) among all participants and tested 
possible interactions by comparing these linear 
effect estimates.
The potential sex-linked modification 
of the relationship between NHL risk and 
exposure to DDT, cis-nonachlor, and oxy-
chlordane was also evaluated by introducing 
interaction terms into the model and testing 
by the Wald test. Finally, analyses were strati-
fied by the time from adipose sampling to 
disease diagnosis for DDT, cis-nonachlor, and 
oxychlordane because stronger associations 
between NHL and organo  chlorine levels were 
previously reported in early (< median) com-
pared with late (≥ median) follow-up periods 
in a study of three unrelated cohorts (Engel 
et al. 2007).
Relationships between the different lipid-
adjusted PCB congeners and pesticide analytes 
detected over LOD were assessed among non-
cases by the Spearman rank correlation. 
Results
At baseline, cases were older (median, 64 
years of age; range, 51–77 years) than subco-
hort persons (median, 56 years of age; range, 
50–65 years), 53% of cases and 46% of sub-
cohort persons were obese (BMI ≥ 26), and 
sex distribution among cases (47% female) 
and subcohort persons (49% female) was 
similar. Organo  chlorines were quantified in 
most adipose tissue samples for p,p´-DDE, 
β-hexachlorocyclohexane, trans-nonachlor, 
hexachlorobenzene, and PCB congeners and 
in at least 56% of samples for the remaining 
organo  chlorines (Table 1).
When controlling for age, sex, and BMI, 
we found suggestions of a monotonic dose–
response relationship in association with con-
centrations of DDT and cis-nonachlor, with 
respective IRRs for the highest versus lowest 
exposure categories of 1.64 (95% CI: 0.68, 
3.96) and 2.52 (95% CI: 1.04, 6.09; Table 2). 
In the linear analyses, IRRs for IQR increases 
in exposure to DDT, cis-nonachlor and oxy-
chlordane were 1.35 (95% CI: 1.10, 1.66), 
1.13 (95% CI: 0.94, 1.36), and 1.11 (95% CI: 
0.89, 1.38), respectively (Table 2). Estimates 
with and without adjusting for BMI (in addi-
tion to controlling for sex and age) were simi-
lar in both the linear and categorical analyses 
(Table 2). BMI did not significantly mod-
ify the effect of any of the organo  chlorines, 
and p-values for the interaction were ≥ 0.16. 
Furthermore, the effects among obese per-
sons (BMI ≥ 26) were not consistent for all 
the organo  chlorines, with enhanced effects 
observed for some and decreased effects for oth-
ers (data not shown). We found no significant 
association or consistent trend between NHL 
risk and adipose concentrations of the five 
other pesticides or the chlordanes and DDT 
sums (Table 2), nor did we find any linear risk 
pattern for any of the individual PCB conge-
ners or their sums (Table 3). We found higher 
relative risk estimates among men than women 
in association with DDT, cis-nonachlor, and 
oxychlordane (Table 4).
The correlation between the organo-
chlorine pesticides varied, with generally low 
correlations for dieldrin, hexachlorobenzene, 
and the other pesticides [rSpearman (rS) mostly 
< 0.30], strong correlations between the chlor-
danes (rS = 0.74–0.91), and moderate correla-
tion for the other pesticides (rS = 0.30–0.50). 
The PCBs were moderately to highly cor-
related with each other [rS = 0.25–0.98; for 
a complete listing of correlation coefficients, 
see Supplemental Material, Table S2, (http://
dx.doi.org/10.1289/ehp.1103573)].
We found no significant difference in 
NHL risk among persons diagnosed in early 
follow-up (< 9.6 years after baseline) com-
pared with those diagnosed in late follow-up 
[≥ 9.6 years after baseline; see Supplemental 
Material, Table S3 (http://dx.doi.org/10.1289/
ehp.1103573)]. Sensitivity analyses assign-
ing persons with organo  chlorine levels below 
the LOD to the lowest exposure category (if 
the LOD for the actual sample was below the 
25th percentile) or to a separate exposure cate-
gory (for the remaining samples below the 
LOD) showed results similar to those from 
analyses excluding samples below the LOD 
(see Supplemental Material, Table S4).
Discussion
In this study, we found that lipid concentra-
tions of DDT, cis-nonachlor, and oxychlor-
dane in a general Danish population were 
associated with elevated risk of NHL. A posi-
tive monotonic dose–response relationship 
was suggested for DDT and cis-nonachlor, 
Table 1. Organo  chlorines in adipose tissue from case and subcohort members.
IQR (all; 
μg/kg lipid)
Above LOD [n (%)]
Median (5th–95th percentile; 
μg/kg lipid)
Compound Cases Subcohort Cases Subcohort
p,p´-DDT 21 137 (57.3) 137 (55.9) 24 (9–83) 21 (10–58)
p,p´-DDE 710 238 (99.6) 237 (96.7) 700 (180–2,400) 640 (170–2,300)
β-Hexachlorocyclohexane 32 225 (94.1) 220 (89.8) 59 (31–110) 56 (33–115)
cis-Nonachlor 4.7 155 (64.9) 156 (63.7) 8.1 (3.5–17.0) 6.8 (3.1–16.0)
trans-Nonachlor 21 235 (98.3) 232 (94.7) 35 (17–76) 32 (16–71)
Oxychlordane 14 169 (70.7) 171 (69.8) 26 (15–47) 23 (12–45)
Dieldrin 16 140 (58.6) 144 (59.0) 24 (9–49) 18 (8–49)
Hexachlorobenzene 35 204 (85.4) 213 (86.9) 54 (20–120) 52 (19–110)
PCB-118 23 233 (97.5) 233 (95.1) 34 (16–70) 35 (17–72)
PCB-156 13 235 (98.3) 236 (96.3) 34 (20–61) 34 (21–57)
PCB-99 16.5 171 (71.5) 177 (72.2) 28 (14–57) 26 (12–53)
PCB-138 80 238 (99.6) 243 (99.2) 150 (57–270) 140 (66–260)
PCB-153 130 239 (100.0) 244 (99.6) 300 (170–470) 300 (160–510)
PCB-170 43 238 (99.6) 243 (99.2) 100 (65–170) 100 (68–170)
PCB-180 70 239 (100.0) 245 (100.0) 200 (120–340) 200 (130–320)
PCB-183 12 226 (94.6) 227 (92.7) 25 (11–40) 24 (12–47)
PCB-187 22 238 (99.6) 240 (98.0) 58 (29–92) 56 (30–99)
PCB-201 8 224 (93.7) 227 (92.7) 19 (11–33) 19 (11–31)Bräuner et al.
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but the positive trend was less consistent for 
oxychlordane. The estimated effect of all three 
compounds was strongest among men. We 
observed no clear or consistent evidence of 
associations between NHL and adipose con-
centrations of PCB congeners or the other 
pesticides included in this study.
These data support the hypothesis of a 
link between DDT and the risk of NHL as 
suggested by some early occupational studies 
(Baris et al. 1998; Cantor et al. 1992; Woods 
et al. 1987). However, most previous studies 
reported no association (De Roos et al. 2003, 
2005; Hardell and Eriksson 1999; Rothman 
et al. 1997; Spinelli et al. 2007), including 
three with exposures measured in blood sam-
ples. In light of the high level of correlation 
between DDT measured in adipose and blood 
(Archibeque-Engle et al. 1997; Stellman 
et al. 1998; Whitcomb et al. 2005), we would 
expect a degree of interchangeability and little 
discrepancy in health results pertaining to 
this compound. We also found no association 
between DDE and NHL risk, which could 
be expected because DDE is more stable than 
DDT, was detected at levels over LOD in 
> 97% of adipose samples, and may therefore 
represent a more accurate biomarker of expo-
sure than DDT. Thus, we cannot exclude the 
possibility that the observed association with 
DDT is a false-positive result.
Results for individual chlordanes are 
limited, and only four previous studies have 
considered the associations between NHL 
and chlordane isomers or the metabolite oxy-
chlordane (De Roos et al. 2005; Hardell et al. 
2001; Quintana et al. 2004; Spinelli et al. 
2007). Results are mixed: one group found 
an association with oxychlordane but not cis- 
nonachlor (Spinelli et al. 2007), whereas 
another found an association with cis-
  nonachlor but not oxychlordane (Hardell 
et al. 2001). Two other groups studied only 
oxychlordane; one found results in accord 
with ours (Quintana et al. 2004), whereas the 
other found no association (De Roos et al. 
2005). The persistence, bioaccumulation, and 
distribution in human tissue as well as toxic 
effects of each individual chlordane depend on 
its chemical structure, so we cannot compare 
our results for cis-nonachlor and oxychlordane 
with the results of studies that considered the 
sum of chlordanes only (Cantor et al. 2003; 
De Roos et al. 2003; McDuffie et al. 2001).
We observed no association between NHL 
and PCBs, in contrast with previous studies 
that reported associations with PCB concen-
trations in blood (Bertrand et al. 2010; De 
Roos et al. 2005; Engel et al. 2007; Hardell 
et al. 2001; Rothman et al. 1997; Spinelli 
et al. 2007). The individual congeners used 
when calculating the PCB sum and the actual 
individual PCB congeners associated with 
NHL differed between studies, but three of 
these studies reported an association between 
PCB-180 and NHL (Bertrand et al. 2010; 
De Roos et al. 2005; Spinelli et al. 2007). We 
detected this congener over LOD in 100% 
of our adipose samples but did not observe 
an association with NHL in our study popu-
lation. Three previous studies have reported 
no association, in accordance with our find-
ings (Cocco et al. 2008; Laden et al. 2010; 
Quintana et al. 2004), including one that 
measured PCBs in adipose tissue samples 
(Quintana et al. 2004). The choice of biologi-
cal specimen used in exposure quantification 
may lead to discrepant human health results 
Compound/concentrationa 
(μg/kg lipids)
n (cases/
subcohort)
IRR (95% CI)
Model 1b Model 2c
p,p´-DDT
6–15 29/37 1.00 1.00
15–22 32/32 1.09 (0.54, 2.18) 1.06 (0.52, 2.14)
22–36 35/38 1.12 (0.57, 2.19) 1.03 (0.51, 2.09)
36–49 23/19 1.25 (0.55, 2.80) 1.21 (0.53, 2.75)
49–460 18/11 1.73 (0.72, 4.14) 1.64 (0.68, 3.96)
Linear estimate per IQRd 137/137 1.36 (1.11, 1.68) 1.35 (1.10, 1.66)
p,p´-DDE
68–390 59/58 1.00 1.00
390–680 53/64 0.82 (0.49, 1.37) 0.83 (0.49, 1.39)
680–1,100 63/57 1.03 (0.62, 1.72) 1.04 (0.62, 1.73)
1,100–1,700 34/36 0.82 (0.45, 1.50) 0.79 (0.43, 1.46)
1,700–8,000 29/22 1.12 (0.58, 2.17) 1.10 (0.57, 2.14)
Linear estimate per IQRd 238/237 1.03 (0.86, 1.22) 1.02 (0.86, 1.22)
β-Hexachlorocyclohexane
15–45 50/60 1.00 1.00
45–57 50/54 1.15 (0.67, 1.99) 1.15 (0.66, 2.00)
57–77 61/58 1.27 (0.74, 2.17) 1.24 (0.72, 2.15)
77–96 38/25 1.59 (0.83, 3.03) 1.49 (0.76, 2.92)
96–370 26/23 1.06 (0.53, 2.11) 1.02 (0.50, 2.07)
Linear estimate per IQRd 225/220 0.99 (0.83, 1.17) 0.96 (0.81, 1.15)
cis-Nonachlor
3–5 30/50 1.00 1.00
5–7 35/42 1.23 (0.64, 2.35) 1.19 (0.61, 2.30)
7–10 42/32 1.56 (0.82, 2.96) 1.53 (0.80, 2.91)
10–15 27/21 1.64 (0.79, 3.41) 1.76 (0.84, 3.67)
15–39 21/11 2.60 (1.08, 6.27) 2.52 (1.04, 6.09)
Linear estimate per IQRd 155/156 1.13 (0.94, 1.36) 1.13 (0.94, 1.36)
trans-Nonachlor
6–25 47/67 1.00 1.00
25–33 53/52 1.33 (0.78, 2.28) 1.39 (0.81, 2.39)
33–46 65/60 1.40 (0.84, 2.36) 1.43 (0.85, 2.40)
46–62 41/33 1.37 (0.75, 2.52) 1.38 (0.75, 2.54)
62–290 29/20 1.60 (0.79, 3.24) 1.54 (0.76, 3.14)
Linear estimate per IQRd 235/232 1.03 (0.90, 1.18) 1.01 (0.89, 1.16)
Compound/concentrationa 
(μg/kg lipids)
n (cases/
subcohort)
IRR (95% CI)
Model 1b Model 2c
Oxychlordane
8–19 30/52 1.00 1.00
19–25 38/46 1.31 (0.71, 2.43) 1.33 (0.72, 2.46)
25–33 46/39 1.87 (1.00, 3.49) 1.86 (1.00, 3.47)
33–41 34/18 2.81 (1.28, 6.14) 2.69 (1.22, 5.96)
41–354 21/16 1.95 (0.85, 4.46) 1.92 (0.84, 4.41)
Linear estimate per IQRd 169/171 1.13 (0.92, 1.40) 1.11 (0.89, 1.38)
Dieldrin
6–13 33/32 1.00 1.00
13–20 21/52 0.38 (0.19, 0.76) 0.36 (0.17, 0.73)
20–29 35/37 0.95 (0.49, 1.85) 0.91 (0.46, 1.79)
29–41 22/12 2.05 (0.92, 4.54) 1.94 (0.87, 4.34)
41–350 18/11 1.42 (0.60, 3.36) 1.27 (0.52, 3.12)
Linear estimate per IQRd 140/144 1.03 (0.94, 1.14) 1.03 (0.94, 1.13)
Hexachlorobenzene
9–37 47/56 1.00 1.00
37–53 50/51 1.08 (0.62, 1.88) 1.07 (0.61, 1.87)
53–72 45/56 0.84 (0.48, 1.49) 0.77 (0.42, 1.43)
72–98 37/33 1.15 (0.60, 2.18) 1.07 (0.55, 2.09)
98–360 25/17 1.25 (0.57, 2.72) 1.16 (0.53, 2.58)
Linear estimate per IQRd 204/213 1.00 (0.82, 1.21) 0.98 (0.80, 1.19)
ΣChlordanese
9–37 55/59 1.00 1.00
37–58 51/68 0.77 (0.46, 1.30) 0.75 (0.44, 1.27)
58–83 64/53 1.18 (0.70, 1.99) 1.10 (0.64, 1.91)
83–108 35/35 0.84 (0.45, 1.55) 0.80 (0.43, 1.50)
108–439 30/17 1.41 (0.68, 2.94) 1.32 (0.63, 2.79)
Linear estimate per IQRf 235/232 1.04 (0.86, 1.26) 1.02 (0.84, 1.24)
ΣDDTsg
76–390 57/56 1.00 1.00
390–690 57/67 0.86 (0.51, 1.43) 0.87 (0.52, 1.47)
690–1,100 61/56 1.02 (0.61, 1.72) 1.03 (0.61, 1.74)
1,100–1,714 36/37 0.86 (0.48, 1.56) 0.83 (0.46, 1.52)
1,714–8,041 27/21 1.09 (0.56, 2.15) 1.08 (0.55, 2.14)
Linear estimate per IQRh 238/237 1.03 (0.87, 1.23) 1.03 (0.86, 1.23)
Table 2. IRRs of NHL in association with adipose tissue concentrations of organo  chlorine pesticides.
aThe cutoffs between the exposure groups were the 25th, 50th, 75th, and 90th percentiles. bAge as time scale; model stratified according to sex. cAge as time scale; model stratified 
according to sex and adjusted for BMI (continuous variable). dLinear estimate per IQR based on pesticide concentrations analyzed as continuous variables. eSum of cis-nonachlor, 
trans-nonachlor, and oxychlordane. fIQRΣChlordanes = 46.2 μg/kg. gSum of DDT and DDE. hIQRΣDDTs = 710 μg/kg.Non-Hodgkin lymphoma and organochlorine exposure
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among studies. Our study is the first to use 
prospectively sampled adipose tissue in expo-
sure assessment. Adipose tissue is the principal 
storage medium for lipophilic organo  chlorines 
in the human body (Anderson 1985) and has 
been regarded by various authors (Allam and 
Lucena 2001; Hardell et al. 1996; Quintana 
et al. 2004) as the preferred indicator of 
human exposure because it represents cumula-
tive internal exposure. Blood samples, which 
have been used to assess exposure in four pre-
vious studies (Cantor et al. 2003; De Roos 
et al. 2005; Hardell et al. 2001; Spinelli et al. 
2007), are more easily obtained and less costly 
but may represent more recent exposure than 
levels in adipose samples collected at the same 
time (Archibeque-Engle et al. 1997).
The limited sample size is a weak-
ness of this study, which limited the power 
to detect statistically significant interactions 
with sex and prevented analyses of association 
for specific NHL subtypes. A better statisti-
cal power would have been achieved with a 
larger sample size (e.g., by selecting a larger 
subcohort), but organo  chlorine analysis costs 
were a constraint. Further, the age distribution 
between the cases and subcohort was quite dif-
ferent, which is expected as the incidence rate 
for NHL increases with age, and cases were 
generally older than the subcohort members. 
In our analyses, however, we used age as the 
time scale, which is recommended to avoid 
bias when analyzing the effect of covariates 
that correlate with age (Thiebaut and Benichou 
2004). Another limitation of this study in rela-
tion to some of the pesticides is the number of 
samples with concentrations below the LOD. 
It can be argued that the exclusion of these 
samples in the present study could introduce 
bias. Thus, we investigated the sensitivity of our 
results related to assignment of organo  chlorine 
levels below the LOD to the lowest exposure 
group if the LOD for the actual sample was 
below the 25th percentile (the cutoff between 
the two lower exposure categories). We found 
our results robust in these analyses. Retaining 
samples below the LOD, for example, by 
imputing LOD/√
–
2 as their value, is advisable 
only in cases in which < 5–10% of samples are 
below LOD (Lubin et al. 2004). This strategy 
is problematic in the present study because 
individual LODs depend on the amount of 
adipose tissue in that particular sample, such 
that LOD varied by up to two orders of mag-
nitude between samples below LOD for the 
same organo  chlorine. Thus, imputing these 
LODs might mask or reverse true associations.
Compound/concentrationa 
(μg/kg lipids)
n (cases/
subcohort)
IRR (95% CI)
Model 1b Model 2c
PCB-118
10–25 53/50 1.00 1.00
25–34 63/62 0.97 (0.57, 1.66) 0.88 (0.50, 1.56)
34–48 58/56 1.00 (0.59, 1.71) 0.96 (0.55, 1.65)
48–62 34/38 0.78 (0.42, 1.45) 0.67 (0.34, 1.31)
62–150 25/27 0.79 (0.40, 1.55) 0.72 (0.36, 1.44)
Linear estimate per IQRd 233/233 0.92 (0.72, 1.17) 0.88 (0.68, 1.14)
PCB-156
13–28 62/53 1.00 1.00
28–34 51/63 0.56 (0.33, 0.96) 0.59 (0.34, 1.02)
34–41 54/59 0.64 (0.38, 1.09) 0.68 (0.40, 1.16)
41–50 45/35 0.83 (0.46, 1.50) 0.94 (0.51, 1.75)
50–88 23/26 0.57 (0.28, 1.15) 0.66 (0.31, 1.37)
Linear estimate per IQRd 235/236 0.95 (0.75, 1.20) 1.01 (0.79, 1.29)
PCB-99
9–20 32/49 1.00 1.00
20–27 42/41 1.63 (0.88, 3.02) 1.60 (0.85, 3.01)
27–37 53/44 1.59 (0.87, 2.91) 1.56 (0.84, 2.89)
37–47 24/27 1.20 (0.58, 2.48) 1.20 (0.58, 2.49)
47–110 20/16 1.45 (0.61, 3.43) 1.42 (0.59, 3.40)
Linear estimate per IQRd 171/177 1.10 (0.83, 1.44) 1.09 (0.83, 1.43)
PCB-138
29–100 53/49 1.00 1.00
100–140 44/69 0.66 (0.38, 1.13) 0.66 (0.38, 1.14)
140–180 74/63 1.05 (0.63, 1.75) 1.04 (0.62, 1.74)
180–230 41/34 1.25 (0.67, 2.31) 1.25 (0.67, 2.33)
230–380 26/28 0.68 (0.34, 1.34) 0.68 (0.34, 1.36)
Linear estimate per IQRd 238/243 0.99 (0.78, 1.25) 0.99 (0.78, 1.26)
PCB-153
98–240 56/55 1.00 1.00
240–300 57/61 0.87 (0.52, 1.47) 0.88 (0.52, 1.50)
300–370 56/73 0.64 (0.38, 1.07) 0.67 (0.40, 1.12)
370–430 42/28 1.38 (0.75, 2.53) 1.50 (0.81, 2.78)
430–730 28/27 0.79 (0.39, 1.57) 0.85 (0.42, 1.73)
Linear estimate per IQRd 239/244 0.94 (0.75, 1.19) 0.97 (0.77, 1.23)
PCB-170
37–87 57/61 1.00 1.00
87–100 47/41 1.09 (0.63, 1.89) 1.19 (0.68, 2.09)
100–130 69/78 0.79 (0.48, 1.30) 0.93 (0.54, 1.59)
130–150 42/32 1.16 (0.64, 2.08) 1.46 (0.75, 2.83)
150–230 23/31 0.64 (0.32, 1.29) 0.80 (0.38, 1.69)
Linear estimate per IQRd 238/243 0.89 (0.68, 1.18) 0.98 (0.72, 1.33)
Compound/concentrationa 
(μg/kg lipids)
n (cases/
subcohort)
IRR (95% CI)
Model 1b Model 2c
PCB-180
71–170 53/60 1.00 1.00
170–200 55/52 0.94 (0.56, 1.67) 1.03 (0.60, 1.77)
200–240 61/54 1.04 (0.62, 1.83) 1.19 (0.69, 2.05)
240–290 49/48 0.98 (0.50, 1.59) 1.09 (0.59, 2.01)
290–480 21/31 0.54 (0.27, 1.08) 0.69 (0.32, 1.46)
Linear estimate per IQRd 239/245 0.90 (0.75, 1.08) 0.99 (0.77, 1.27)
PCB-183
6–19 59/53 1.00 1.00
19–24 35/54 0.59 (0.34, 1.05) 0.58 (0.32, 1.03)
24–31 69/60 0.92 (0.55, 1.53) 0.91 (0.54, 1.51)
31–39 40/34 1.03 (0.56, 1.90) 1.03 (0.56, 1.90)
39–65 23/26 0.66 (0.33, 1.31) 0.68 (0.34, 1.37)
Linear estimate per IQRd 226/227 0.87 (0.70, 1.08) 0.88 (0.70, 1.10)
PCB-187
17–46 61/58 1.00 1.00
46–56 49/62 0.68 (0.40, 1.15) 0.69 (0.40, 1.17)
56–68 62/60 0.90 (0.54, 1.51) 0.97 (0.57, 1.64)
68–84 44/33 1.12 (0.60, 2.07) 1.30 (0.68, 2.47)
84–140 22/27 0.62 (0.30, 1.27) 0.69 (0.33, 1.44)
Linear estimate per IQRd 238/240 0.88 (0.71, 1.11) 0.92 (0.73, 1.15)
PCB-201
6–15 43/47 1.00 1.00
15–19 62/61 0.91 (0.52, 1.59) 0.98 (0.56, 1.73)
19–23 58/47 1.10 (0.62, 1.97) 1.20 (0.66, 2.21)
23–28 36/44 0.69 (0.37, 1.29) 0.82 (0.41, 1.67)
28–45 25/28 0.73 (0.34, 1.56) 0.88 (0.38, 2.03)
Linear estimate per IQRd 224/227 0.85 (0.64, 1.13) 0.93 (0.68, 1.28)
ΣPCBe
150–770 62/59 1.00 1.00
770–939 55/66 0.74 (0.45, 1.24) 0.74 (0.44, 1.24)
939–1,143 57/62 0.78 (0.47, 1.30) 0.81 (0.48, 1.35)
1,143–1,351 42/32 1.08 (0.59, 1.95) 1.15 (0.63, 2.11)
1,351–2,157 23/26 0.65 (0.32, 1.33) 0.71 (0.34, 1.45)
Linear estimate per IQRf 239/245 0.95 (0.76, 1.19) 0.99 (0.79, 1.25)
ΣPCBimmune
g
150–530 60/58 1.00 1.00
530–650 55/63 0.77 (0.46, 1.30) 0.79 (0.47, 1.34)
650–790 59/65 0.77 (0.47, 1.29) 0.82 (0.49, 1.38)
790–930 42/32 1.15 (0.64, 2.09) 1.29 (0.70, 2.38)
930–1,490 23/27 0.62 (0.31, 1.26) 0.68 (0.33, 1.41)
Linear estimate per IQRh 239/245 0.95 (0.76, 1.18) 0.99 (0.78, 1.24)
Table 3. IRRs for NHL and 95% CI in association with adipose tissue concentrations of PCBs.
aThe cutoffs between exposure groups were: 25th, 50th, 75th, and 90th percentiles. bAge as time scale; model stratified according to sex. cAge as time scale; model stratified according 
to sex and adjusted for BMI (continuous variable). dLinear estimate per IQR range based on PCB concentrations analyzed as continuous variables. eSum of PCB congeners. fIQRΣPCB = 
373 μg/kg. gSum of suggested immunotoxic PCB congeners 138, 153, and 180. hIQRΣPCBimmune = 260 μg/kg.Bräuner et al.
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Two studies have estimated associa-
tions between organo  chlorines measured in 
adipose tissue and NHL risk. The first was 
a small study that examined only summed 
chlordanes (Hardell et al. 1996) in samples 
obtained after diagnosis (in cases), whereas 
the other used adipose samples taken post 
mortem (Quintana et al. 2004). Prospective 
studies are advantageous when investigating 
carcinogenic effects exerted years before clini-
cal presentation, whereas organo  chlorine lev-
els in adipose samples collected after diagnosis 
have been shown to be affected by treatment 
(Gammon et al. 1996) and weight loss (Glynn 
et al. 2003; Jandacek et al. 2005) and to pos-
sibly alter metabolic function (Morgan and 
Roan 1971; Mullerova and Kopecky 2007), 
which could be related to weight fluctuations, 
ultimately affecting organo  chlorine levels. We 
sampled adipose tissue up to 15 years before 
the NHL diagnosis, and given the relatively 
long half-lives of DDT, cis-nonachlor, and 
oxychlordane (up to 6 years), our prospective 
measures represent a relatively stable internal 
dose that is likely to reflect exposures several 
years before follow-up for cancer started.
We are the first group to report associa-
tions between NHL and DDT, cis-nonachlor, 
and oxychlordane mainly (or possibly only) 
among men. Eight previous studies consid-
ered both sexes, but only one investigated sex-
specific effects of DDT on NHL (Miligi et al. 
2003) and reported no association for either 
sex. The stronger associations among men in 
our study population may be due to differ-
ences in metabolism and elimination of the 
compounds (e.g., women can excrete these 
compounds via breast-feeding).
Some studies have suggested that BMI 
could confound associations between organo-
chlorine concentrations and NHL, although 
this is controversial (Cox et al. 1999). A 
positive association between high BMI and 
organo  chlorines may be expected in relation to 
prolonged consumption of fatty foods, which 
are often associated with overweight and pos-
sibly a high intake of lipophilic compounds; 
conversely, however, a high BMI and body fat 
content could result in a dilution effect. We 
investigated whether persons with a high BMI 
had greater risk of NHL than persons with low 
BMI, analyzing data both with and without 
adjusting for BMI, and found no evidence of 
effect modification or confounding. BMI was 
measured at the time of enrollment/adipose 
sampling, which is relevant for assessing the 
effect of BMI on the adipose sample but does 
not reflect effects of BMI over time.
The timing of diagnosis relative to the 
organo  chlorine measurement has been inves-
tigated in only one previous study (Engel et al. 
2007), which reported a stronger exposure–
response association among subjects diagnosed 
within the years before median follow-up 
(early follow-up) compared with subjects diag-
nosed in the years after median follow-up (late 
follow-up). We observed no significant differ-
ences related to the duration of follow-up and 
thus could not confirm this result.
The major strength of this study is the pro-
spective collection of adipose tissue samples in 
a general population setting. Follow-up was 
virtually complete, and reliable nationwide 
regis  tries provided information on vital status 
and cancer. Selection bias is unlikely because 
cases and subcohort participants came from 
the same cohort and fulfilled the same eligibil-
ity criteria. Further, recall bias was avoided by 
the objective exposure assessment method, and 
disease status could not have biased exposure 
assessment because adipose tissue was obtained 
and frozen before cancer diagnosis.
The exact mechanisms by which organo-
chlorines might increase NHL risk remain to 
be elucidated but the involvement of immuno-
suppression is suspected. Evidence of the 
immunotoxicity of organo  chlorines (includ-
ing DDT and chlordane) has been reviewed, 
and both human and toxicological evidence 
suggests immunotoxicity (Repetto and Baliga 
1997). More recent animal and in vitro stud-
ies confirm this for DDT and individual 
chlordanes (Reed et al. 2004; Tryphonas 
et al. 2003); however, this evidence is com-
posed mainly of acute high-dose studies, and 
the relevance to typical human exposure levels 
may be questioned. It remains unclear which 
specific compounds are related to NHL risk 
and whether this association is causal. We can-
not rule out confounding from unaccounted 
risk factors, for example, other more toxic 
agents such as furans, dioxins, or coplanar 
PCBs that are bioaccumulated in parallel with 
DDT, cis-nona  chlor, and oxychlordane. More 
research is needed to clarify possible interac-
tions with organo  chlorines and other agents 
such as viruses and genetic polymorphisms to 
further elucidate biological mechanisms behind 
this association.
Conclusion
Our results add new evidence of an association 
between exposure to DDT and chlordanes and 
NHL at prospectively measured exposure levels 
experienced by a general population but do 
not contribute to the evidence that exposure to 
PCB congeners may increase the risk of NHL.
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